15(R)-Prostaglandin E1,
20897-91-0,
UNII-V2N896SN9V,
CHEMBL62570,
15R-PGE1,
V2N896SN9V,
9-oxo-11R,15R-dihydroxy-13E-prostaenoic acid,
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15R)-,
15-Epiprostaglandin E1,
15R-Prostaglandin E1,
AC1NR1FD,
15-epi-PGE1,
Alprostadil impurity D [EP],
SCHEMBL11786980,
15(R)-PGE1,
HMS3648D07,
ZINC3830202,
1213AH,
BDBM50101828,
LMFA03010055,
SR-01000946408,
J-013704,
SR-01000946408-1,
7-((1R,2R,3R)-3-Hydroxy-2-((1E,3R)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid,
7-((1R,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid,
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid,
7-[(1R,2R,3R)-3-Hydroxy-2-((E)-(R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-heptanoic acid,
alprostadil,
PGE1,
FA(20:1(OH2,Ke,cyclo)),
C20H34O5,
CID5283056,